TABLE 4.

Comparison of improvement in assessment scores among groups, including only patients at Hoehn and Yahr stages 1 and 2, given as mean±standard deviation

% Improvement ratios	Study Group n=13	Control Group n=10	Significance level (one-tailed)
UPDRS-II*	34±21	9±12	p=0.003
BBS**	8±5	4±2	p=0.049
TUG***	20±17	6±10	p=0.026

^*Unified Parkinson Disease Rating Scale was used.

^**Berg balance scale was used.

^***Timed Up-and-Go Test was used.